Profile data is unavailable for this security.
About the company
Treace Medical Concepts, Inc. is a medical technology company. It is advancing the standard of care for the surgical management of bunion and related midfoot deformities. It has patented the Lapiplasty 3D Bunion Correction System a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. It has Adductoplasty Midfoot Correction System, designed for reproducible surgical correction of midfoot deformities, the SpeedMTP Rapid Compression Implant for addressing bunions through big toe joint fusions, and two systems for minimally invasive osteotomy surgeries: the Nanoplasty 3D Minimally Invasive Bunion Correction System and the Percuplasty Percutaneous 3D Bunion Correction System. It sells its products to physicians, surgeons, ambulatory surgery centers, hospitals, and stocking distributors.
- Revenue in USD (TTM)218.88m
- Net income in USD-50.11m
- Incorporated2014
- Employees477.00
- LocationTreace Medical Concepts Inc100 Palmetto Park PlacePONTE VEDRA 32081United StatesUSA
- Phone+1 (904) 373-5940
- Fax+1 (904) 834-7169
- Websitehttps://www.treace.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Vivani Medical Inc | 0.00 | -26.03m | 101.51m | 42.00 | -- | 58.74 | -- | -- | -0.4417 | -0.4417 | 0.00 | 0.0213 | 0.00 | -- | -- | 0.00 | -76.61 | -43.12 | -94.91 | -49.69 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 8.44 | -- | 2.43 | -- |
| Hyperfine Inc | 10.59m | -40.05m | 110.70m | 111.00 | -- | 3.29 | -- | 10.45 | -0.5243 | -0.5243 | 0.1385 | 0.3339 | 0.191 | 0.8859 | 1.81 | 95,414.41 | -72.23 | -45.05 | -88.25 | -48.86 | 46.12 | 30.47 | -378.17 | -757.55 | 3.06 | -- | 0.00 | -- | 16.84 | -- | 7.95 | -- | 9.44 | -- |
| Alpha Teknova Inc | 39.80m | -18.22m | 112.95m | 173.00 | -- | 1.55 | -- | 2.84 | -0.3409 | -0.3409 | 0.7446 | 1.36 | 0.3435 | 3.77 | 8.17 | 230,063.60 | -15.73 | -19.57 | -16.94 | -20.97 | 30.97 | 38.24 | -45.78 | -63.70 | 4.27 | -28.65 | 0.1525 | -- | 2.89 | 12.68 | 27.28 | -- | -16.96 | -- |
| Picard Medical Inc | 4.77m | -33.80m | 118.66m | 75.00 | -- | 14.89 | -- | 24.86 | -0.4673 | -0.4673 | 0.066 | 0.1081 | -- | -- | -- | 63,653.33 | -- | -- | -- | -- | -10.03 | -- | -660.85 | -- | 0.9373 | -0.7808 | 0.0134 | -- | -12.93 | -- | -31.86 | -- | -- | -- |
| Pro-Dex Inc | 70.23m | 11.19m | 121.92m | 181.00 | 11.35 | 2.99 | 9.80 | 1.74 | 3.35 | 3.35 | 21.03 | 12.73 | 1.18 | 2.65 | 4.40 | 388,016.60 | 18.87 | 12.06 | 23.88 | 15.24 | 28.09 | 29.81 | 15.94 | 11.73 | 2.14 | -- | 0.2418 | 0.00 | 23.68 | 13.84 | 322.10 | 7.99 | 19.14 | -- |
| Neuronetics Inc | 129.87m | -44.50m | 123.27m | 716.00 | -- | 4.50 | -- | 0.9492 | -0.8344 | -0.8344 | 2.24 | 0.3997 | 1.18 | 13.87 | 7.31 | 181,386.90 | -40.63 | -29.61 | -52.56 | -36.96 | 50.43 | 74.98 | -34.35 | -53.71 | 2.09 | -4.31 | 0.6768 | -- | 4.96 | 3.63 | -44.78 | -- | 12.51 | -- |
| Treace Medical Concepts Inc | 218.88m | -50.11m | 128.71m | 477.00 | -- | 1.44 | -- | 0.588 | -0.7947 | -0.7947 | 3.48 | 1.40 | 1.07 | 1.04 | 7.66 | 458,865.80 | -24.47 | -24.03 | -30.34 | -29.17 | 79.87 | 80.99 | -22.89 | -24.97 | 2.36 | -22.69 | 0.3829 | -- | 11.89 | 39.65 | -12.55 | -- | 57.11 | -- |
| Fonar Corp | 105.43m | 6.99m | 136.58m | 535.00 | 17.84 | 0.696 | 9.74 | 1.30 | 1.04 | 1.04 | 15.74 | 26.69 | 0.4897 | 22.33 | 1.28 | 197,073.50 | 4.34 | 6.77 | 4.42 | 7.19 | 41.07 | 45.46 | 8.86 | 13.74 | 8.46 | -- | 0.0021 | -- | 1.43 | 4.02 | -21.26 | 0.1719 | -12.96 | -- |
| LifeMD Inc | 252.34m | -7.71m | 140.08m | 304.00 | -- | 103.15 | 28.37 | 0.5551 | -0.1711 | -0.1711 | 5.66 | 0.0282 | 3.64 | 10.83 | 33.00 | 830,075.60 | -4.29 | -109.71 | -31.14 | -396.03 | 86.96 | 85.59 | -1.18 | -33.12 | 0.6645 | 0.3164 | 0.00 | -- | 39.27 | 76.32 | 7.23 | -- | -- | -- |
| Cibus Inc | 3.79m | -118.90m | 141.91m | 157.00 | -- | 2.18 | -- | 37.40 | -3.26 | -3.26 | 0.0972 | 0.9588 | 0.0109 | -- | 4.23 | 24,165.61 | -36.11 | -80.24 | -39.32 | -89.98 | -- | -- | -3,322.54 | -1,268.46 | -- | -2.18 | 0.8131 | -- | 134.56 | -10.19 | 6.07 | -- | -22.92 | -- |
| Citrine Global Corp | 0.00 | -1.74m | 141.93m | 18.00 | -- | -- | -- | -- | -0.0016 | -0.0016 | 0.00 | -0.0031 | 0.00 | -- | -- | 0.00 | -118.80 | -238.43 | -- | -- | -- | -- | -- | -186,483.40 | -- | -2.10 | -- | -- | -- | -- | 25.99 | -- | -- | -- |
| Anika Therapeutics Inc | 82.20m | 13.91m | 147.82m | 288.00 | 10.88 | 1.01 | 7.31 | 1.80 | 0.9419 | -2.28 | 5.70 | 10.18 | 0.3907 | 0.486 | 3.25 | 285,430.60 | 6.61 | -1.87 | 7.39 | -2.06 | 54.29 | 60.74 | 16.92 | -4.73 | 4.47 | -- | 0.00 | -- | -0.7327 | 0.9077 | -156.70 | -- | 24.14 | -- |
| LENSAR Inc | 59.14m | -51.52m | 148.35m | 140.00 | -- | -- | -- | 2.51 | -4.39 | -4.39 | 4.99 | -1.02 | 0.8946 | 1.79 | 11.51 | 422,435.70 | -77.94 | -32.69 | -121.49 | -38.95 | 46.15 | 51.51 | -87.12 | -54.77 | 0.6671 | -- | -- | -- | 26.87 | 11.87 | -118.34 | -- | -40.48 | -- |
| InfuSystem Holdings Inc | 141.05m | 5.52m | 154.76m | 502.00 | 29.09 | 2.79 | 8.17 | 1.10 | 0.2616 | 0.2616 | 6.65 | 2.73 | 1.38 | 10.25 | 5.79 | 280,984.10 | 5.41 | 4.50 | 6.56 | 5.46 | 55.35 | 55.24 | 3.92 | 3.86 | 1.60 | 7.73 | 0.274 | 0.00 | 7.22 | 10.70 | 168.92 | 11.50 | -4.62 | -- |
| Nano-X Imaging Ltd | 12.30m | -55.71m | 155.03m | 165.00 | -- | 0.9346 | -- | 12.60 | -0.8839 | -0.8839 | 0.195 | 2.40 | 0.0683 | 13.17 | 7.18 | 74,557.58 | -30.95 | -28.17 | -33.30 | -31.20 | -98.04 | -- | -452.82 | -1,072.25 | 3.93 | -- | 0.0201 | -- | 13.91 | -- | 11.95 | -- | 85.79 | -- |
| Lucid Diagnostics Inc | 4.40m | -65.84m | 157.11m | 72.00 | -- | -- | -- | 35.71 | -0.8968 | -0.8968 | 0.0526 | 0.1973 | 0.1161 | 12.24 | 14.94 | 61,097.22 | -140.60 | -139.37 | -301.55 | -297.39 | -58.13 | -- | -1,211.30 | -2,492.79 | 1.88 | -- | 0.4633 | -- | 79.00 | -- | -0.6817 | -- | -- | -- |
Data as of Feb 12 2026. Currency figures normalised to Treace Medical Concepts Inc's reporting currency: US Dollar USD
38.56%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Armistice Capital LLCas of 30 Sep 2025 | 6.32m | 9.91% |
| William Blair Investment Management LLCas of 30 Sep 2025 | 3.63m | 5.70% |
| BlackRock Fund Advisorsas of 30 Sep 2025 | 3.26m | 5.11% |
| Gagnon Securities LLCas of 30 Sep 2025 | 2.26m | 3.54% |
| The Vanguard Group, Inc.as of 31 Dec 2025 | 1.93m | 3.03% |
| Millennium Management LLCas of 30 Sep 2025 | 1.71m | 2.68% |
| CIBC Private Wealth Advisors, Inc.as of 30 Sep 2025 | 1.69m | 2.65% |
| First Eagle Investment Management LLCas of 31 Dec 2025 | 1.46m | 2.30% |
| JPMorgan Investment Management, Inc.as of 30 Sep 2025 | 1.17m | 1.84% |
| Geode Capital Management LLCas of 30 Sep 2025 | 1.15m | 1.80% |
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
